Allergan and Co-Defendants to Pay $9 Million for Product-Hopping to Stifle Generics

Allergan, Senju and Kyorin agreed to pay pharmaceuticals purchaser Hartig Drug $9 million to settle a product -hopping class-action lawsuit.
Source: Drug Industry Daily